FI906273A - Foereningar foer behandling av inflammatorisk tarmsjukdom. - Google Patents

Foereningar foer behandling av inflammatorisk tarmsjukdom. Download PDF

Info

Publication number
FI906273A
FI906273A FI906273A FI906273A FI906273A FI 906273 A FI906273 A FI 906273A FI 906273 A FI906273 A FI 906273A FI 906273 A FI906273 A FI 906273A FI 906273 A FI906273 A FI 906273A
Authority
FI
Finland
Prior art keywords
tarmsjukdom
inflammatorisk
foereningar
benzyl
rhodanine derivatives
Prior art date
Application number
FI906273A
Other languages
English (en)
Other versions
FI104251B (fi
FI104251B1 (fi
FI906273A0 (fi
Inventor
Jaswant Singh Gidda
Jill Ann Panetta
Michael Leroy Phillips
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI906273A0 publication Critical patent/FI906273A0/fi
Publication of FI906273A publication Critical patent/FI906273A/fi
Application granted granted Critical
Publication of FI104251B publication Critical patent/FI104251B/fi
Publication of FI104251B1 publication Critical patent/FI104251B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Surgical Instruments (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Eye Examination Apparatus (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI906273A 1989-12-21 1990-12-19 Menetelmä tulehduksellisten suolistosairauksien hoitoon käyttökelpoisten yhdisteiden valmistamiseksi FI104251B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45420389A 1989-12-21 1989-12-21
US45420389 1989-12-21

Publications (4)

Publication Number Publication Date
FI906273A0 FI906273A0 (fi) 1990-12-19
FI906273A true FI906273A (fi) 1991-06-22
FI104251B FI104251B (fi) 1999-12-15
FI104251B1 FI104251B1 (fi) 1999-12-15

Family

ID=23803709

Family Applications (2)

Application Number Title Priority Date Filing Date
FI906273A FI104251B1 (fi) 1989-12-21 1990-12-19 Menetelmä tulehduksellisten suolistosairauksien hoitoon käyttökelpoisten yhdisteiden valmistamiseksi
FI991698A FI19991698A (fi) 1989-12-21 1999-08-10 Menetelmä selektiivisesti eristää, oleellisesti puhtaassa enantiomeerisessä muodossa, raseemisten bentsyylisubstituoitujen rodaniinijohdannaisten enantiomeerejä

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI991698A FI19991698A (fi) 1989-12-21 1999-08-10 Menetelmä selektiivisesti eristää, oleellisesti puhtaassa enantiomeerisessä muodossa, raseemisten bentsyylisubstituoitujen rodaniinijohdannaisten enantiomeerejä

Country Status (22)

Country Link
EP (1) EP0434394B1 (fi)
JP (1) JP3036853B2 (fi)
KR (1) KR0176243B1 (fi)
CN (1) CN1029846C (fi)
AT (1) ATE169294T1 (fi)
AU (1) AU639734B2 (fi)
CA (1) CA2032330C (fi)
CY (1) CY2100B1 (fi)
DE (1) DE69032537T2 (fi)
DK (1) DK0434394T3 (fi)
ES (1) ES2121748T3 (fi)
FI (2) FI104251B1 (fi)
HU (1) HU216732B (fi)
IE (1) IE904633A1 (fi)
IL (3) IL96654A (fi)
MX (1) MX23803A (fi)
NO (1) NO300458B1 (fi)
NZ (1) NZ236472A (fi)
PT (1) PT96198B (fi)
RU (2) RU2036915C1 (fi)
YU (1) YU240690A (fi)
ZA (1) ZA9010041B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87339A1 (fr) * 1988-09-20 1990-04-06 Oreal Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
NZ248573A (en) * 1992-09-10 1996-02-27 Lilly Co Eli 5-arylmethyl (and methylidene) thiazolidin-4-one derivatives; their preparation and pharmaceutical compositions
DE69301894T2 (de) * 1992-10-28 1996-11-07 Shionogi & Co Benzylidenderivate
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US5563277A (en) * 1994-12-21 1996-10-08 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
TW460471B (en) * 1995-09-07 2001-10-21 Lilly Co Eli Alternate crystal form of tazofelone
PT761657E (pt) * 1995-09-07 2000-11-30 Lilly Co Eli Processo de preparacao de derivados de rodanina benzil-substituidos
EP0779282A1 (en) * 1995-12-14 1997-06-18 Eli Lilly And Company Thiomorpholinone compounds for treating multiple sclerosis
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone
US6005142A (en) * 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
WO2000018746A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
WO2000018747A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
WO2000018748A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
MXPA05003366A (es) * 2002-09-30 2005-10-05 Univ California Inhibidores de la proteina reguladora de conductancia transmembranal de la fibrosis quistica y usos de los mismos.
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
US8846982B2 (en) * 2010-04-15 2014-09-30 Merck Patent Gmbh Process for the preparation of hydroquinones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79648A (en) * 1985-08-09 1991-12-12 Lilly Co Eli Pharmaceutical anti-inflammatory and ischemia preventing compositions containing di-t-butylphenol derivatives,some such novel compounds and process for their preparation
IE940525L (en) * 1988-05-25 1989-11-25 Warner Lambert Co Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
CA2013599C (en) * 1989-04-07 1999-11-16 Jill A. Panetta Aryl-substituted rhodanine derivatives

Also Published As

Publication number Publication date
NZ236472A (en) 1993-03-26
DE69032537T2 (de) 1999-01-21
RU2036915C1 (ru) 1995-06-09
DK0434394T3 (da) 1998-12-14
HU216732B (hu) 1999-08-30
YU240690A (sh) 1992-12-21
CN1052668A (zh) 1991-07-03
ZA9010041B (en) 1992-08-26
FI104251B (fi) 1999-12-15
AU6826690A (en) 1991-06-27
KR0176243B1 (ko) 1999-03-20
CN1029846C (zh) 1995-09-27
IE904633A1 (en) 1991-07-17
CA2032330C (en) 2001-05-08
RU2050355C1 (ru) 1995-12-20
FI104251B1 (fi) 1999-12-15
ATE169294T1 (de) 1998-08-15
KR910011812A (ko) 1991-08-07
FI19991698A (fi) 1999-08-10
NO905478D0 (no) 1990-12-19
CY2100B1 (en) 2002-04-05
IL108962A0 (en) 1994-06-24
MX23803A (es) 1994-02-28
HUT59915A (en) 1992-07-28
EP0434394B1 (en) 1998-08-05
FI906273A0 (fi) 1990-12-19
NO905478L (no) 1991-06-24
EP0434394A2 (en) 1991-06-26
PT96198A (pt) 1991-09-30
AU639734B2 (en) 1993-08-05
EP0434394A3 (en) 1992-01-08
ES2121748T3 (es) 1998-12-16
NO300458B1 (no) 1997-06-02
CA2032330A1 (en) 1991-06-22
IL108962A (en) 1996-12-05
PT96198B (pt) 1998-05-29
DE69032537D1 (de) 1998-09-10
HU908368D0 (en) 1991-07-29
JP3036853B2 (ja) 2000-04-24
IL96654A (en) 1995-06-29
JPH04279573A (ja) 1992-10-05

Similar Documents

Publication Publication Date Title
FI906273A0 (fi) Foereningar foer behandling av inflammatorisk tarmsjukdom.
DE68913860D1 (de) Pressform und Formgebungsverfahren zum Herstellen von optischen Teilen.
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
NO874350D0 (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
IS2666B (is) Aðferð við ljósfræðilega hreinsun á bensimidasólafleiðum með hækkað hlutfall enantíómera
AT383130B (de) Verfahren zur herstellung von an c1 und c2 verschieden substituierten phosphatidylcholinen und phosphatidylethanolaminen ueber die neuen verbindungen 1-0-tritylglycerophosphocholin beziehungsweise (1-0,n-ditrityl)-glycerophosphoethanolamin
HUT56356A (en) Process for producing thiazolidin-4-ones and 1,3-oxathiolan-5-one derivatives
DE3676922D1 (de) Neue polyoxygenierte labdan-derivate, verfahren zu ihrer herstellung und ihre anwendung als medikamente.
PT97547A (pt) Processo para a preparacao de novas pirido {2,3-f}{1,4}tiazepinas e pirido {3,2-b}{1,5}benzotiazepinas e de composicoes farmaceuticas que as contem
ATE65779T1 (de) Verfahren zur herstellung von carbinolderivaten.
AU8204091A (en) Process for producing enantiomers of 2-aryl-alkanoic acids
DE69527802D1 (de) Verfahren zur herstellung von benzyl-substituierten rhodanin derivaten
CS53688A2 (en) Method of new substituted 3-phenyl-7h-thiazolo/3,2-b//1,2,4/triazine -7-ons production
FR2647959B1 (fr) Procede de fabrication simultanee de transistors mos a canal n et de transistors bipolaires verticaux pnp
NO950952L (no) Fremgangsmåte for fremstilling av pilokarpin
NO174713C (no) Fremgangsmåte for separasjon av enantiomerer av benzopyranderivater.
DE69112670D1 (de) Hexahydrobenzo[cd]indole und Verfahren zu deren Herstellung.
HU9203625D0 (en) Stereoselective process for producing optical isomers of 1-benzoyl-4-hydroxi-5-(1-phenyl-ethyl)-amino-1,2,2a,3,4,5-hexahydrobenz/cd/-indole
DE3864286D1 (de) Herstellungsverfahren von trifluormethylverbindungen.
NO980937L (no) Fremgangsmåte for fremstilling av benzyl-substituerte rhodaninderivater

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ELI LILLY AND COMPANY